RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: lupus nephritis
Accession: DOID:0080162
browse the term
Definition: A glomerulonephritis that is characterized by inflammation of the kidneys resulting from systemic lupus erythematosus. (DO)
Synonyms: exact_synonym: Lupus Glomerulonephritides; Lupus Glomerulonephritis; Lupus Nephritides; SLE nephritis; Systemic Lupus Erythematosus with Nephritis
related_synonym: SLEN1; SLEN2; SLEN3; Systemic Lupus Erythematosus with Nephritis, Susceptibility To, 1; Systemic Lupus Erythematosus with Nephritis, Susceptibility To, 2; Systemic Lupus Erythematosus with Nephritis, Susceptibility To, 3; lupus nephritis, susceptibility to
primary_id: MESH:D008181
alt_id: DOID:9004124
xref: EFO:0005761 ; GARD:10747 ; MIM:607965 ; MIM:607966 ; MIM:607967
G
Ager
advanced glycosylation end product-specific receptor
ISO
DNA:polymorphisms:promoter, intron:g.-429T>C rs1800625, g.-374T>A rs1800624, g.2184A>G rs3134940 (human)
RGD
PMID:22513366
RGD:6767309
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,147,890...4,151,078
G
Apoc3
apolipoprotein C3
ISO
protein:increased expression:serum
RGD
PMID:17957542
RGD:7207211
NCBI chr 8:55,428,172...55,430,352
Ensembl chr 8:46,531,478...46,533,583
G
C3
complement C3
ISO
protein:decreased expression:serum CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:31182691 PMID:21888025
RGD:7175544
NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,087,437...2,114,429
G
Ccl2
C-C motif chemokine ligand 2
severity susceptibility
ISO
protein:increased expression:urine (human) DNA:snp:promoter:g.-2518A>G (human)
RGD
PMID:8558841 PMID:15188361
RGD:8549732 , RGD:11528534
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
G
Ccl3
C-C motif chemokine ligand 3
ISO
RGD
PMID:18187931
RGD:7241814
NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,451,388...68,452,938
G
Ccr1
C-C motif chemokine receptor 1
disease_progression
ISO
RGD
PMID:15153561
RGD:5688164
NCBI chr 8:132,433,711...132,439,266
G
Cd40
CD40 molecule
treatment
ISO
RGD
PMID:23799000 PMID:19265127 PMID:18566369
RGD:7248418 , RGD:7248425 , RGD:7248429
NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:153,790,449...153,805,534
G
Cd40lg
CD40 ligand
treatment
ISO
protein:increased expression:serum
RGD
PMID:20726330 PMID:15693003 PMID:13130474 PMID:12632425 PMID:11751940
RGD:7248426 , RGD:7248439 , RGD:7248600 , RGD:7248710 , RGD:7248714
NCBI chr X:140,164,341...140,176,057
Ensembl chr X:135,126,969...135,138,306
G
Cfb
complement factor B
ISO
RGD
PMID:10623824 PMID:21893562 PMID:3183062
RGD:7242736 , RGD:7242755 , RGD:7242763
NCBI chr20:3,975,271...3,981,138
Ensembl chr20:3,951,474...3,976,505
G
Cfh
complement factor H
ISO
RGD
PMID:22171659
RGD:5684551
NCBI chr13:54,063,079...54,164,523
Ensembl chr13:51,511,828...51,613,838
G
Clu
clusterin
ISO
mRNA:increased expression: epithelial cell of renal tubule
RGD
PMID:9546356
RGD:8890679
NCBI chr15:44,336,619...44,375,861
Ensembl chr15:40,174,617...40,200,315
G
Col1a1
collagen type I alpha 1 chain
ISO
mRNA, protein:increased expression:kidney cortex associated with Graft vs Host Disease
RGD
PMID:21354048 PMID:7723234 PMID:7700025
RGD:5688301 , RGD:5688332 , RGD:5688333
NCBI chr10:80,380,458...80,397,461
Ensembl chr10:79,883,622...79,900,624
G
Crp
C-reactive protein
no_association
ISO
DNA:SNP
RGD
PMID:18852001 PMID:15692982 PMID:20039408 PMID:17596285
RGD:6907400 , RGD:6909145 , RGD:6909146 , RGD:5508454
NCBI chr13:87,694,062...87,695,978
Ensembl chr13:85,124,977...85,175,178
G
Csf1
colony stimulating factor 1
ISO
RGD
PMID:21885670 PMID:17659436
RGD:7257567 , RGD:7257589
NCBI chr 2:198,065,400...198,084,774
Ensembl chr 2:195,377,215...195,411,704
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
ISO
RGD
PMID:15146424
RGD:7204726
NCBI chr 9:69,812,859...69,819,959
Ensembl chr 9:62,319,312...62,324,963
G
Egf
epidermal growth factor
ISO
RGD
PMID:21354048
RGD:5688301
NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:218,219,415...218,302,064
G
Fas
Fas cell surface death receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33632240 PMID:38555047
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:231,798,960...231,832,591
G
Fcgr2a
Fc gamma receptor 2A
ISO
DNA:missense mutation:cds:p.H131R (human) ClinVar Annotator: match by term: Lupus nephritis, susceptibility to
ClinVar RGD
PMID:8636449 PMID:9843982 PMID:10675363 PMID:15367919 PMID:19915573 PMID:19965803 PMID:24033266 PMID:25741868 PMID:15004265 More...
RGD:5147975
NCBI chr13:85,813,516...85,830,269
Ensembl chr13:83,280,784...83,295,967
G
Fcgr2b
Fc gamma receptor 2B
ISO
RGD
PMID:15681388
RGD:7240529
NCBI chr13:85,725,897...85,740,517
Ensembl chr13:83,193,163...83,207,778
G
Fcgr3a
Fc gamma receptor 3A
susceptibility
ISO
DNA:SNP:cds:p.V158F (human)
RGD
PMID:17596285
RGD:5508454
NCBI chr13:85,782,636...85,792,656
Ensembl chr13:83,249,872...83,259,921
G
Ifng
interferon gamma
ISO
protein:increased expression:serum,urine protein:increased processing:kidney CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:31182691 PMID:22764573 PMID:29925830
RGD:6893369 , RGD:14974252
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375
G
Il17a
interleukin 17A
treatment
ISO
RGD
PMID:25129462
RGD:9244623
NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:23,144,402...23,147,889
G
Il18
interleukin 18
ISO
RGD
PMID:20980973
RGD:6893449
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:50,906,960...50,932,887
G
Il1b
interleukin 1 beta
ISO
mRNA:increased expression:renal glomerulus (mouse)
RGD
PMID:21641991 PMID:20410215
RGD:7175315 , RGD:7175344
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il1rn
interleukin 1 receptor antagonist
resistance
ISO
associated with Lupus Erythematosus, Systemic; protein:increased expression:serum (human)
RGD
PMID:20538031
RGD:6907068
NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:7,111,550...7,127,445
G
Itgam
integrin subunit alpha M
ISO
RGD
PMID:21719445
RGD:5147916
NCBI chr 1:192,089,496...192,139,947
Ensembl chr 1:182,659,000...182,709,503
G
Jak1
Janus kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31182691
NCBI chr 5:120,895,606...121,004,207
Ensembl chr 5:115,780,248...115,888,926
G
Klkb1
kallikrein B1
susceptibility
ISO
DNA:SNPs:promoter:
RGD
PMID:19307730
RGD:7327150
NCBI chr16:53,690,180...53,714,570
Ensembl chr16:46,958,707...46,982,053
G
Mbl2
mannose binding lectin 2
disease_progression
ISO
DNA:polymorphism:exon:
RGD
PMID:24850777
RGD:12910847
NCBI chr 1:237,429,873...237,465,567
G
Mir125a
microRNA 125a
IEP
RNA:decreased expression:kidney
RGD
PMID:30972208
RGD:26884458
NCBI chr 1:58,677,626...58,677,710
Ensembl chr 1:58,677,626...58,677,710
G
Mmp2
matrix metallopeptidase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22479529
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:14,154,657...14,182,870
G
Mmp9
matrix metallopeptidase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22479529
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120
G
Mpo
myeloperoxidase
susceptibility
ISO
DNA:polymorphism: :−463G > A (human)
RGD
PMID:17896805
RGD:7174701
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:72,594,661...72,604,819
G
Mtor
mechanistic target of rapamycin kinase
ISO
RGD
PMID:17283580
RGD:7245502
NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:158,884,804...158,994,311
G
Muc20
mucin 20, cell surface associated
ISO
RGD
PMID:14565953
RGD:7364790
NCBI chr11:67,987,816...68,001,496
Ensembl chr11:67,987,800...68,001,495
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
ISO
RGD
PMID:21509671 PMID:17880936
RGD:7174713 , RGD:7174734
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,271,681...31,393,375
G
Otub1
OTU deubiquitinase, ubiquitin aldehyde binding 1
ISO
protein:increased expression:kidney
RGD
PMID:22279542
RGD:7175260
NCBI chr 1:204,387,215...204,395,495
Ensembl chr 1:204,387,215...204,395,483
G
Pdcd1
programmed cell death 1
onset
ISO
DNA:polymorphism: : DNA:polymorphism:intron:6867 C>T (human)
RGD
PMID:15934088 PMID:15352422 PMID:21041733
RGD:7248675 , RGD:7248676 , RGD:7248678
NCBI chr 9:101,866,124...101,879,278
Ensembl chr 9:94,418,791...94,431,937
G
RT1-Ba
RT1 class II, locus Ba
susceptibility
ISO
DNA:polymorphisms:cds:HLA-DQA1*0101 (human) DNA:polymorphisms:cds:HLA-DQA1*0102 (human)
RGD
PMID:12651073
RGD:40902999
NCBI chr20:4,577,057...4,581,650
Ensembl chr20:4,575,134...4,579,744
G
RT1-Db1
RT1 class II, locus Db1
susceptibility
ISO
DNA:polymorphisms:cds:HLA-DRB1*1501 (human)
RGD
PMID:12651073
RGD:40902999
NCBI chr20:4,550,594...4,560,182
Ensembl chr20:4,548,666...4,558,258
G
Sell
selectin L
ISO
RGD
PMID:20512127
RGD:7175284
NCBI chr13:78,950,100...78,969,604
Ensembl chr13:76,416,915...76,436,456
G
Serping1
serpin family G member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:4014294
NCBI chr 3:69,842,726...69,852,583
Ensembl chr 3:69,842,739...69,852,034
G
Snrpe
small nuclear ribonucleoprotein polypeptide E
treatment
IDA
mouse model
RGD
PMID:15494537
RGD:10760401
NCBI chr13:45,050,986...45,057,231
Ensembl chr13:45,050,986...45,057,310 Ensembl chr 8:45,050,986...45,057,310
G
Stat1
signal transducer and activator of transcription 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31182691
NCBI chr 9:56,911,522...56,951,926
Ensembl chr 9:49,419,340...49,588,540
G
Stat4
signal transducer and activator of transcription 4
ISO
RGD
PMID:20980973
RGD:6893449
NCBI chr 9:56,964,617...57,080,523
Ensembl chr 9:49,419,340...49,588,540
G
Stat6
signal transducer and activator of transcription 6
disease_progression
ISO
RGD
PMID:12874250
RGD:7244140
NCBI chr 7:63,480,229...63,497,551
Ensembl chr 7:63,479,642...63,498,495
G
Tlr7
toll-like receptor 7
ISO
RGD
PMID:19944565
RGD:7246905
NCBI chr X:30,644,324...30,670,796
Ensembl chr X:27,027,425...27,054,754
G
Tlr9
toll-like receptor 9
no_association treatment severity
ISO
DNA:snps:intron, exon:g.+1174G>A, g.+1635C>T (rs352139, rs352140) (human, Chinese) associated with Lupus Erythematosus, Systemic; DNA:snps:promoter, intron:g.-1486T>C, g.+1174A>G (rs187084, rs352139) (human, North Indian) protein:increased expression:renal glomerulus (human) associated with Graft vs Host Disease mRNA, protein:increased expression:kidney (mouse)
RGD
PMID:23467932 PMID:20497632 PMID:22787315 PMID:19578108 PMID:21127878 PMID:17469139 More...
RGD:7245987 , RGD:7246884 , RGD:7245989 , RGD:7246896 , RGD:7246897 , RGD:7246911
NCBI chr 8:115,743,407...115,747,523
Ensembl chr 8:106,864,680...106,868,796
G
Tnf
tumor necrosis factor
ISO
protein:increased expression:glomerular mesangial cell
RGD
PMID:7750940
RGD:7394786
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf11b
TNF receptor superfamily member 11B
ISO
associated with Lupus Erythematosus, Systemic;protein:increased expression:urine
RGD
PMID:21691937
RGD:7205483
NCBI chr 7:87,456,318...87,484,324
Ensembl chr 7:85,566,520...85,594,538
G
Tnfrsf1a
TNF receptor superfamily member 1A
severity
ISO
RGD
PMID:19201910 PMID:10906156
RGD:7245569 , RGD:7245572
NCBI chr 4:159,837,119...159,849,817
Ensembl chr 4:158,150,820...158,163,591
G
Tnfrsf1b
TNF receptor superfamily member 1B
treatment
ISO
RGD
PMID:22846145 PMID:22674120
RGD:7245541 , RGD:7245544
NCBI chr 5:162,356,250...162,387,411
Ensembl chr 5:157,070,642...157,104,206
G
Vcam1
vascular cell adhesion molecule 1
severity
ISO
protein:increased expression:urine
RGD
PMID:22788914
RGD:7241032
NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:204,038,114...204,057,958
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all